ciglitazone has been researched along with Prostatic Neoplasms in 8 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The PPAR-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J(2) and ciglitazone, and the PPAR-alpha ligand, WY-14643, were examined for their effects on proliferation and apoptosis of A375 melanoma, DU145 and PC3 prostate cancer, and MB-MDA-231 breast cancer." | 3.73 | PPAR-gamma ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells. ( Liu, H; Meadows, GG; Núñez, NP, 2006) |
| "Human prostate cancer cells were used." | 1.33 | Does the PGC-1/PPARgamma pathway play a role in Com-1/p8 mediated cell growth inhibition in prostate cancer? ( Davies, G; Fodstad, O; Jiang, WG; Kynaston, H; Mason, MD, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lyles, BE | 2 |
| Akinyeke, TO | 1 |
| Moss, PE | 2 |
| Stewart, LV | 2 |
| Gottfried, E | 1 |
| Rogenhofer, S | 1 |
| Waibel, H | 1 |
| Kunz-Schughart, LA | 1 |
| Reichle, A | 1 |
| Wehrstein, M | 1 |
| Peuker, A | 1 |
| Peter, K | 1 |
| Hartmannsgruber, G | 1 |
| Andreesen, R | 1 |
| Kreutz, M | 1 |
| Chen, CH | 1 |
| Huang, PH | 1 |
| Chu, PC | 1 |
| Chen, MC | 1 |
| Chou, CC | 1 |
| Wang, D | 1 |
| Kulp, SK | 1 |
| Teng, CM | 1 |
| Wang, Q | 1 |
| Chen, CS | 3 |
| Núñez, NP | 1 |
| Liu, H | 1 |
| Meadows, GG | 1 |
| Yang, CC | 1 |
| Ku, CY | 1 |
| Wei, S | 1 |
| Shiau, CW | 1 |
| Pinzone, JJ | 1 |
| Ringel, MD | 1 |
| Jiang, WG | 1 |
| Davies, G | 1 |
| Kynaston, H | 1 |
| Mason, MD | 1 |
| Fodstad, O | 1 |
| Laidler, P | 1 |
| Dulińska, J | 1 |
| Mrozicki, S | 1 |
8 other studies available for ciglitazone and Prostatic Neoplasms
| Article | Year |
|---|---|
Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARgamma-dependent and PPARgamma-independent pathways.
Topics: Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibi | 2009 |
Pioglitazone modulates tumor cell metabolism and proliferation in multicellular tumor spheroids.
Topics: Cell Line, Tumor; Cell Proliferation; Chromans; Deoxyglucose; Humans; Hydrogen-Ion Concentration; Hy | 2011 |
The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells.
Topics: Androgen-Binding Protein; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dihydrotestosterone; Gene | 2010 |
Energy restriction-mimetic agents induce apoptosis in prostate cancer cells in part through epigenetic activation of KLF6 tumor suppressor gene expression.
Topics: Acetylation; Apoptosis; Cell Line, Tumor; Epigenesis, Genetic; Gene Expression Regulation, Neoplasti | 2011 |
PPAR-gamma ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells.
Topics: Amino Acids; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferatio | 2006 |
Peroxisome proliferator-activated receptor gamma-independent repression of prostate-specific antigen expression by thiazolidinediones in prostate cancer cells.
Topics: Animals; Cell Line, Tumor; Dihydrotestosterone; Humans; Male; Pioglitazone; PPAR gamma; Prostate-Spe | 2006 |
Does the PGC-1/PPARgamma pathway play a role in Com-1/p8 mediated cell growth inhibition in prostate cancer?
Topics: Basic Helix-Loop-Helix Transcription Factors; Cell Division; Cell Line, Tumor; DNA, Complementary; G | 2006 |
Does the inhibition of c-myc expression mediate the anti-tumor activity of PPAR's ligands in prostate cancer cell lines?
Topics: Anilides; Antineoplastic Agents; Apoptosis; beta Catenin; Cadherins; Cell Differentiation; Cell Line | 2007 |